PI3K/AKT/mTOR Signaling Pathway Is Downregulated by Runzaoling (RZL) in Sjögren’s Syndrome

<div>RZL can regulate SS through the AKT/mTOR pathway. (a) Venn diagram of RZL and SS targets. (b) Venn diagram of the source of SS disease targets. (c) (String) and (d) (Cytoscape) PPI plots of disease and drug intersection targets. (e) Bubble plot of GO biological process enrichment.</div>

Mediators of Inflammation

fig1

Figure 1

Figure 1: PI3K/AKT/mTOR Signaling Pathway Is Downregulated by Runzaoling (RZL) in Sjögren’s Syndrome 